Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Agnus Hevert femin
- Development stage
- Unknown
- Lead developer
- Hevert-Arzneimittel
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Agnus Hevert femin is a homeopathic and herbal combination medicine developed and marketed by Hevert-Arzneimittel for the treatment of menstrual disorders accompanied by nervousness. The formulation contains four active ingredients in homeopathic dilutions: Agnus castus (chaste tree) mother tincture, Cimicifuga (black cohosh) D2, Pulsatilla (pasque flower) D4, and Zincum valerianicum D3. It is designed as a hormone-free alternative to regulate the hypothalamic-pituitary-ovarian axis and corpus luteum function, addressing symptoms such as premenstrual syndrome, mood disturbances, and irritability. The product is administered as oral drops containing 65% alcohol and is intended for women who prefer non-hormonal therapy or for whom hormone treatment is medically inappropriate. Optimal therapeutic effects are typically observed after regular intake over at least three menstrual cycles.
- Brand names
- Agnus Hevert femin
- Other names
- Agnus Hevert femin MischungAgnus Hevert femin oral drops
Beyond the preview
Go deeper on Agnus Hevert femin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Agnus Hevert femin.